KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Depreciation & Amortization - Total (2016 - 2025)

Evolent Health has reported Depreciation & Amortization - Total over the past 11 years, most recently at $6.3 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization - Total at $6.3 million for Q4 2025, down 14.86% from a year ago — trailing twelve months through Dec 2025 was $26.3 million (down 13.2% YoY), and the annual figure for FY2025 was $26.3 million, down 13.2%.
  • Depreciation & Amortization - Total for Q4 2025 was $6.3 million at Evolent Health, roughly flat from $6.3 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization - Total for EVH hit a ceiling of $8.9 million in Q4 2022 and a floor of $6.3 million in Q3 2025.
  • Median Depreciation & Amortization - Total over the past 5 years was $7.6 million (2021), compared with a mean of $7.6 million.
  • Biggest five-year swings in Depreciation & Amortization - Total: grew 14.71% in 2021 and later fell 18.99% in 2025.
  • Evolent Health's Depreciation & Amortization - Total stood at $7.8 million in 2021, then increased by 14.1% to $8.9 million in 2022, then decreased by 14.61% to $7.6 million in 2023, then decreased by 2.63% to $7.4 million in 2024, then fell by 14.86% to $6.3 million in 2025.
  • The last three reported values for Depreciation & Amortization - Total were $6.3 million (Q4 2025), $6.3 million (Q3 2025), and $6.4 million (Q2 2025) per Business Quant data.